Form 4 for RNAC Cartesian Therapeutics, Inc.
Accepted 2025-12-18 00:00:00 ET · period of report 2025-12-16 · accession 0001453687-25-000144 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-12-18 | 2025-12-16 | RNAC | Bot Adrian Ion | Dir | A - Grant | $0.00 | +5,800 | 5,800 | New | $0 |
| D | 2025-12-18 | 2025-12-16 | RNAC | Bot Adrian Ion | Dir | A - Grant | $0.00 | +17.2K | 17.2K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-12-16 | A | A | 5,800 | $0.00 | 5,800 | D | — | — | |
| 2 | Derivative | Stock Option (Right to Buy) | 2025-12-16 | A | A | 17,200 | $0.00 | 17,200 | D | $8.29 · — to 2035-12-15 | 17,200 Common Stock | (F2) This award will vest in 36 equal monthly installments, so that it shall be fully vested on December 16, 2028. |